DROSHA and nasopharyngeal carcinoma: Reduced expression level of Drosha was found in melanoma (Jafarnejad et al., 2013), ovarian cancer (Papachristou et al., 2012), neuroblastoma (Lin et al., 2010), endometrial cancer (Torres et al., 2011), nasopharyngeal carcinoma (Guo et al., 2012), and gallbladder adenocarcinoma (Shu et al., 2012; Table 3).